This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning (overdose) by alcohol and/or other drugs, and deaths among people who use drugs which are not due to poisoning (non-poisonings) for the period 2008-2017 (HRB Ireland)
Bibliography: All Publications
Trends in drug-induced deaths in Australia, 1997-2018
Each year, the Australian Bureau of Statistics (ABS) makes available to Drug Trends in-depth data on drug-induced deaths in Australia. This year, we have produced a suite of products to summarise trends in drug-induced deaths in Australia from 1997 to 2018 (NDARC)
ACT Pill Testing Trial 2019 (PDF)
Program evaluation (Australian National University)
Needle Syringe Program National Minimum Data Collection Report 2019
The Needle Syringe Program National Minimum Data Collection (NSP NMDC) supports the National Strategies for blood borne and sexually transmissible infections and complements the annual Australian Needle Syringe Program Survey National Data Report (The Kirby Institute, Australia)
Seizures of drugs in England and Wales, financial year ending 2019
Contains figures for seizures of drugs made by local police forces and the UK Border Force (Home Office)
UN Common Position on drug policy – Consolidating system-wide coherence
This briefing paper reconstructs the long and troubled process that led to the adoption of this ground-breaking UN System Common Position (TNI)
Terrorism and drugs in Europe
Despite much speculation and conjecture over potential crossovers between terrorists and the drug trade in Europe, no study has examined the issue. This paper fills this gap by empirically examining such crossovers in the European Union between 2012 and 2017 (EMCDDA)
Drug seizures and arrests in Northern Ireland, period ending 30 September 2019
Six-monthly update of class A, B and C drug seizure incidents and arrests by PSNI (Police Service of Northern Ireland)
Highlights from the EU Drug Markets Report for policy and practice
This short publication presents the main highlights from the EU Drug Markets Report 2019, targeting policy and practice (EMCDDA)
Global State of Harm Reduction: 2019 updates
The 2019 update to Harm Reduction International’s flagship publication, the Global State of Harm Reduction, includes updates to some of the key data in the report, including the opening of new drug consumption rooms, availability of needle and syringe programs, and references to harm reduction in national policy documents, among many other things
Statistics on Drug Misuse, England, 2019
This publication provides a range of information relating to drug misuse drawn from a variety of sources. Topics covered are drug related hospital admissions, deaths related to poisoning by drug misuse, drug use prevalence amongst adults and children, drug dependency, and drug seizures (NHS Digital)
Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS): national overview 2018
Overview of findings on alcohol, drug use and smoking from the 2018 wave of the Scottish Schools Adolescent Lifestyle and Substance Use Survey – SALSUS (Scottish Government)
Substance misuse treatment for young people: statistics 2018 to 2019
Alcohol and drug treatment data for under-18s from PHE’s National Drug Treatment Monitoring System – NDTMS (Public Health England)
Using open-source information to improve the European drug monitoring system
This paper explains the methodology developed by the EMCDDA for open-source information monitoring in the area of drug markets. Initially designed to support the work of the EU Early Warning System in 2016, the technique has recently been expanded to cover open-source information through a pilot project focusing on data on heroin and cocaine seizures of 100 kg or more for the European market between April 2017 and March 2018 (EMCDDA)
Drug precursor developments in the European Union
This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU (EMCDDA)
Methamphetamine in Europe: EMCDDA-Europol threat assessment
This report provides a comprehensive overview of the methamphetamine market in the European Union. It assesses the current threat situation regarding current trends in production, trafficking and distribution (EMCDDA)
EU Drug Markets Report 2019
The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol.
Cannabis-based medicinal products (PDF)
This position statement examines the existing evidence on CBMPs and how they relate to mental health (RC PSYCH, UK)
My world survey: national study of youth mental health in Ireland (PDF)
Large-scale studies that capture the mental health profile of young people help us to understand their experiences and inform service provision. To date, there is a limited body of research on the prevalence of mental health difficulties among young people aged 12-25, particularly in the Irish context (UCD School of Psychology and Headstrong, Ireland)
Circular 009/2019: third generation synthetic cannabinoids update
Amendment to the generic definition of a group of synthetic cannabinoids (‘third generation’) under the Misuse of Drugs Act 1971, Misuse of Drugs Regulations 2001 and the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 (UK Government)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 72
- Next Page »
